chr17-82171725-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001394669.1(CCDC57):c.1858G>A(p.Val620Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000885 in 1,613,026 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001394669.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCDC57 | NM_001394669.1 | c.1858G>A | p.Val620Ile | missense_variant | 12/19 | ENST00000694881.1 | NP_001381598.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCDC57 | ENST00000694881.1 | c.1858G>A | p.Val620Ile | missense_variant | 12/19 | NM_001394669.1 | ENSP00000511565 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000460 AC: 70AN: 152188Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000610 AC: 152AN: 249182Hom.: 0 AF XY: 0.000621 AC XY: 84AN XY: 135186
GnomAD4 exome AF: 0.000930 AC: 1358AN: 1460720Hom.: 1 Cov.: 31 AF XY: 0.000908 AC XY: 660AN XY: 726494
GnomAD4 genome AF: 0.000460 AC: 70AN: 152306Hom.: 0 Cov.: 32 AF XY: 0.000376 AC XY: 28AN XY: 74470
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 23, 2024 | The c.1858G>A (p.V620I) alteration is located in exon 12 (coding exon 11) of the CCDC57 gene. This alteration results from a G to A substitution at nucleotide position 1858, causing the valine (V) at amino acid position 620 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at